News and events

29.02.2008 Mystery Of Glowing Antibody Solved By Scripps Research Scientists

Now, a group of Scripps Research scientists have shown that EP2-19G2, one of a panel of fluorescent monoclonal antibodies that were first reported in ... read more

29.02.2008 New Study: How Cigarette Smoke Causes Cancer

Everyone has known for decades that smoking causes cancer, but until now no one really understood how cigarette smoke causes healthy lung cells to bec... read more

28.02.2008 Step-Parents Influence Teenage Smoking Behaviour, UK

Smoking by a non-biological parent is as influential as smoking by biological parents in determining whether their teenager smokes, reveal the results... read more

27.02.2008 MS Society Offers Another Line Of Support, UK

The MS Society is reaching out to more people affected by multiple sclerosis (MS) than ever before thanks to the launch of an email Helpline facility.... read more

27.02.2008 New Bladder Cancer Therapy For Patients Unresponsive To Standard Treatment

As many as half of patients with superficial bladder cancer do not respond to the standard first-line chemotherapy placed into the bladder, according... read more

26.02.2008 Positive CHMP Opinion For Histologically-Based Use Of ALIMTA(R) (Pemetrexed For Injection) For Most Common Lung Cancer

Eli Lilly and Company (NYSE: LLY)announced that the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issu... read more

25.02.2008 Health Insurer Has To Pay Breast Cancer Patient 9 Million For Cancelling Her Policy

An arbitration judge in California has ruled that one of the state's biggest for-profit medical insurers, Health Net Inc, has to pay breast cancer pa... read more

24.02.2008 Cystoscopy For Lower Urinary Tract Symptoms In Urogynecologic Practice: The Likelihood Of Finding Bladder Cancer

Evanston Northwestern Healthcare, Division of Urogynecology, Department of Obstetrics and Gynecology, Northwestern University Medical School, Evanston... read more

23.02.2008 Merck Serono's Erbitux(R) Cited As 'One Of The Most Significant Advances In The Last 25 Years' In The Treatment Of Head And Neck Cancer

Merck Serono, a division of Merck KGaA of Germany, has won a Frost & Sullivan Customer Value Enhancement (CVE) Award for its epidermal growth factor ... read more

21.02.2008 Controlling Nitric Oxide Levels Could Further Improve Effectivness Of Anticancer Therapies

Manipulating levels of nitric oxide (NO), a gas involved in many biological processes, may improve the disorganized network of blood vessels supplying... read more

Страница 65 из 100

< Previous 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100 Next >